NASDAQ$PAYS
Paysign Inc · Q1 2024 earnings
Q1 2024 earnings · · Investor relations
Briefing
Paysign's financial performance saw revenue increase and adjusted EBITDA growth, driven by the patient affordability business.
Paysign reported a 30% increase in revenue and a 135% increase in adjusted EBITDA compared to the first quarter of the previous year. The patient affordability business grew significantly, with a 305% rise in revenue, becoming a major growth driver for the company. The company confirmed its full-year revenue guidance to be in the range of $54.5 million to $56.7 million and adjusted EBITDA to be in the range of $8.0 million to $9.0 million.
- Revenue increased by 30% compared to Q1 2023.
- Adjusted EBITDA grew by 135% compared to Q1 2023.
- Patient affordability business revenue increased by 305% compared to Q1 2023.
- Gross profit margins improved due to the shift to a greater percentage of pharma revenue.
Headline financials
Revenue & EPS history
Paysign · Revenue · Quarterly
$13.2M
Forward guidance
The company is confirming the guidance they gave in March, for total revenues to be in the range of $54.5 million to $56.7 million and adjusted EBITDA to be in the range of $8.0 million to $9.0 million.
Tailwinds
- Total revenues to be in the range of $54.5 million to $56.7 million.
- Adjusted EBITDA to be in the range of $8.0 million to $9.0 million.
- Total revenue for Q2 2024 is expected to increase by approximately 27.5% over Q2 2023.
- Pharma revenue accounting for approximately 18.0% of the total revenue for Q2.
- Adjusted EBITDA for Q2 is expected to increase 65.0% to 70.0% from Q2 2023.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 18 quarterly earnings reports · overlaid with Q1 2024
+16.2%
Avg return
Earnings day
+4.1%
Avg return
5 days after
+7.8%
Avg return
30 days after
44%
27 / 61 earnings
Positive
+900.0%
Q3 2011
Best reaction
-29.6%
Q4 2015
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q4 2025 | +37.3% | -4.3% | — | |
| Q1 2026 | -12.6% | -12.0% | +4.8% | |
| Q3 2025 | +0.2% | -8.8% | +0.4% | |
| Q2 2025 | +13.0% | +4.2% | +0.6% | |
| Q1 2025 | +3.0% | +22.9% | +81.9% | |
| Q4 2024 | -8.5% | -14.5% | -8.1% | |
| Q3 2024 | +10.9% | +8.7% | -7.9% | |
| Q2 2024 | -6.7% | -14.4% | -9.2% | |
| Q1 2024 | -0.4% | +5.4% | -7.6% | |
| Q4 2023 | +20.5% | +10.2% | +31.9% | |
| Q3 2023 | +18.1% | +21.6% | +18.1% | |
| Q2 2023 | +6.4% | +8.6% | +16.0% | |
| Q1 2023 | -1.8% | -4.5% | -20.7% | |
| Q4 2022 | +4.2% | +7.6% | +0.3% | |
| Q3 2022 | -10.4% | +8.9% | +16.5% | |
| Q2 2022 | +7.4% | +15.3% | +33.5% | |
| Q1 2022 | -26.2% | -20.2% | -2.4% | |
| Q4 2021 | -6.6% | -16.6% | -21.4% | |
| Q3 2021 | -9.0% | -14.6% | -32.8% | |
| Q2 2021 | -2.4% | +5.6% | +16.7% | |
| Q1 2021 | -11.4% | -10.8% | +0.0% | |
| Q4 2020 | +11.7% | +5.1% | +0.8% | |
| Q3 2020 | -26.8% | -20.6% | -7.7% | |
| Q2 2020 | -18.9% | -30.5% | -45.3% | |
| Q1 2020 | -5.5% | -13.0% | -0.4% | |
| Q4 2019 | +27.3% | +82.9% | +102.7% | |
| Q3 2019 | +13.2% | +17.1% | +3.9% | |
| Q2 2019 | +2.5% | +6.3% | +2.7% | |
| Q1 2019 | -11.7% | -6.7% | +18.2% | |
| Q4 2018 | -1.7% | -7.5% | -1.0% | |
| Q3 2018 | -0.5% | -1.6% | -6.3% | |
| Q2 2018 | +10.1% | +2.7% | -2.7% | |
| Q1 2018 | -0.9% | +18.8% | +23.1% | |
| Q4 2017 | +19.0% | +20.6% | +44.3% | |
| Q3 2017 | +7.9% | +19.3% | +15.8% | |
| Q2 2017 | +2.8% | +9.4% | +0.0% | |
| Q1 2017 | -8.7% | -6.5% | -6.5% | |
| Q4 2016 | +4.7% | +0.0% | +0.0% | |
| Q3 2016 | +34.9% | +73.7% | +73.7% | |
| Q2 2016 | +0.0% | -5.0% | -20.0% | |
| Q1 2016 | -23.2% | — | — | |
| Q4 2015 | -29.6% | — | — | |
| Q3 2015 | -12.0% | — | — | |
| Q2 2015 | +6.3% | — | — | |
| Q1 2015 | +4.3% | — | — | |
| Q4 2014 | +71.2% | — | — | |
| Q2 2014 | -16.7% | — | — | |
| Q1 2014 | +0.0% | — | — | |
| Q4 2013 | +23.4% | — | — | |
| Q3 2013 | -17.9% | — | — | |
| Q2 2013 | -16.6% | — | — | |
| Q4 2012 | -4.3% | — | — | |
| Q1 2013 | -4.3% | — | — | |
| Q3 2012 | +18.5% | — | — | |
| Q2 2012 | +0.0% | — | — | |
| Q1 2012 | +0.0% | — | — | |
| Q4 2011 | +0.0% | — | — | |
| Q3 2011 | +900.0% | — | — | |
| Q2 2011 | +0.0% | — | — | |
| Q1 2011 | +0.0% | — | — | |
| Q4 2010 | +5.0% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro